Navigation Links
Omnicell To Present At Lazard Capital Markets 9th Annual Healthcare Conference
Date:11/7/2012

MOUNTAIN VIEW, Calif., Nov. 7, 2012 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at Lazard Capital Markets 9th Annual Healthcare Conference at the Pierre Hotel, New York, NY. 

(Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO and Rob Seim, executive vice president & CFO

Date: Wednesday, November 14, 2012   
Time: 10:30 a.m. ET   
Location: The Pierre Hotel, New York, NY   
Availability: The audio-webcast of the live presentation may be accessed by visiting:    
http://ir.omnicell.com/events.cfm

Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.

About Omnicell
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automation and business information solutions enabling hospitals and other healthcare organizations to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a customer's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.

Since 1992, more than 2,600 hospital customers worldwide have utilized Omnicell's medication automation, supply chain, and analytics solutions to enable them to increase patient safety, improve efficiency and address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursement and inventory management of medications and supplies.

MTS Medication Technologies, a wholly-owned Omnicell subsidiary, is a leader in medication adherence packaging systems designed to improve medication dispensing and administration. MTS enables approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards while optimizing productivity and controlling costs. The MTS product line includes more than 20 packaging machines and 50 types of consumable products.

For more information about Omnicell, please visit www.omnicell.com. Visit www.mts-mt.com for more information about MTS. 

OMCL-E


'/>"/>
SOURCE Omnicell, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Omnicell Announces Record Revenue and Profit in Third Quarter 2012
2. Omnicell To Present At Think Equitys 9th Annual Growth Conference: G9
3. Omnicell Announces Second Quarter 2012 Results
4. University of South Alabama Health System Selects Omnicell G4 Solutions
5. Omnicell to Release Second Quarter 2012 Earnings Results on August 1
6. Omnicell Repeats Best in KLAS Award for OmniRx Automated Medication Dispensing System
7. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
8. Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
9. PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference
10. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
11. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... The primary goal of this research is to analyze ... of liquid biopsy. Key information the survey seeks to ... liquid biopsy adoption amidst future users - Predominantly used ... Sample inflow to conduct liquid biopsy tests - Preference ... on. - Correlation analysis of sample type and biomarker ...
(Date:2/11/2016)... PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for its ... also filed its Quarterly Report on Form 10-Q for the ... Exchange Commission today. --> --> ... --> Net sales for the three months ... $5.4 million from $2.8 million for the three months ended ...
(Date:2/11/2016)... 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ), ... lives of pets, today announced the submission to FDA ... Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive ... Zimeta for the control of pyrexia (fever) in horses ... --> --> The Chemistry, Manufacturing, and ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... ... initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce ... from U.S. universities who will draw from Siemens’ deep knowledge of product ...
(Date:2/12/2016)... ... ... Each year, the American Physical Therapy Association (APTA) offers a Combined Sections Meeting. ... Almost 10,000 physical therapists across the country are expected to attend this annual convention ... field and network with their colleagues. As in years past, HydroWorx is proud ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
(Date:2/12/2016)... ... , ... AssureVest Insurance Group, a locally owned insurance firm with offices serving ... funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and 3rd grade ... a low-income area and has more than 60 2nd and 3rd graders with learning ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... the Pittsburgh metro area, celebrates the beginning of the latest charity campaign in ... social skills through art. Donations to this worthy cause are currently being accepted ...
Breaking Medicine News(10 mins):